Recursion Pharmaceuticals Q1 2026 Earnings Narrowed Loss Beats Estimates Amid Pipeline Progress Blue Owl Capital Corporation OBDC Q1 2026 Earnings EPS Misses Estimates but Stock Posts Modest Gain INDP Q4 2025 Earnings EPS Misses Estimates as PreClinical Costs Continue Stock Declines 9 LASR Q1 2026 Earnings EPS Surges Past Estimates Stock Gains Amid Strategic Shifts Milestone Pharmaceuticals MIST Q1 2026 Earnings EPS Miss Deepens as ClinicalStage Biotech Navigates Development Path Morningstar Inc MORN Q1 2026 Earnings EPS Surges Past Estimates on Strong Operating Performance